AG

Ankurkumar Gopalbhai Bhalodiya

Active Director Director DIN 07778407
DIN 07778407 First appointment Mar 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Mar 2017
Shareholding value •••• Premium profile

About Ankurkumar Gopalbhai Bhalodiya

Data last updated:

Ankurkumar Gopalbhai Bhalodiya is a Director at Zeon Biotech Private Limited (since 2018), Director at Auroma Life Science Private Limited (since 2017) and Director at Bombay Generics Private Limited (since 2021), and holds 2 more current directorships. The companies operate in Pharma, BFSI and Engineering. The 3 current companies with reported revenue have a combined latest revenue of ₹25.25 Cr; the largest is Zeon Biotech Private Limited at ₹24.10 Cr (FY 2024). Earlier, Ankurkumar Gopalbhai Bhalodiya was a Director at Aan Lifescience Private Limited (2017–2019).

DIN 07778407
Primary Designation Director
Industry Pharma
First Appointment 28 Mar 2017
Oldest Company Age 37 yrs
Largest company Zeon Biotech Private Limited · ₹24.10 Cr (FY 2024)
Combined revenue ₹25.25 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Zeon Biotech Private Limited U24306GJ2018PTC101881
Director17 Apr 20182018₹24.10 Cr (FY 2024)Active
Auroma Life Science Private Limited U24231GJ2003PTC043309
Director28 Mar 20172003₹1.01 Cr (FY 2024)Active
Bombay Generics Private Limited U24231GJ1989PTC012305
Director01 Feb 20211989₹14.8 Lakh (FY 2024)Active
Zeon Capital Limited U64990GJ2025PLC164705
Director02 Jul 20252025Active
Designated Partner10 Jul 20172017Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aan Lifescience Private Limited U36990GJ2017PTC099793
Director14 Nov 20172017₹31.79 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bombay Generics Private Limited
Auroma Life Science Private Limited
Zeon Biotech Private Limited
Aplus Engitech Llp
Premium access

Shareholding and investment profile for Ankurkumar Gopalbhai Bhalodiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankurkumar Gopalbhai Bhalodiya

Ankurkumar Gopalbhai Bhalodiya currently holds 5 directorships: Zeon Biotech Private Limited (Director, since 17 Apr 2018, revenue ₹24.10 Cr (FY 2024)); Auroma Life Science Private Limited (Director, since 28 Mar 2017, revenue ₹1.01 Cr (FY 2024)); Bombay Generics Private Limited (Director, since 01 Feb 2021, revenue ₹14.8 Lakh (FY 2024)); Zeon Capital Limited (Director, since 02 Jul 2025); Aplus Engitech Llp (Designated Partner, since 10 Jul 2017).

Ankurkumar Gopalbhai Bhalodiya was first appointed on 28 Mar 2017 as Director at Auroma Life Science Private Limited. The most recent appointment on record is 02 Jul 2025 at Zeon Capital Limited.

The 3 current companies of Ankurkumar Gopalbhai Bhalodiya that report revenue have a combined latest revenue of ₹25.25 Cr: Zeon Biotech Private Limited ₹24.10 Cr (FY 2024); Auroma Life Science Private Limited ₹1.01 Cr (FY 2024); Bombay Generics Private Limited ₹14.8 Lakh (FY 2024).

Ankurkumar Gopalbhai Bhalodiya held 1 earlier board appointment: Aan Lifescience Private Limited (Director, 14 Nov 2017 to 25 May 2019).

The current boards of Ankurkumar Gopalbhai Bhalodiya's companies include Dimpal Bhalodiya (Zeon Biotech Private Limited), Krushnakant Bhalodia (Zeon Biotech Private Limited), Poojaben Bhalodiya (Zeon Biotech Private Limited), Bakulkumar Jayantilal Padia (Bombay Generics Private Limited), Bharatkumar Babulal Patel (Bombay Generics Private Limited), Krunal Dilipkumar Sanghavi (Bombay Generics Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available